DAVID B. SIEGEL, MD

TUCSON, AZ

Research Active
Orthopaedic Surgery - Hand Surgery NPI registered 21+ years 50 publications 2023 – 2026 NPI: 1235133182
MiceMice, Inbred C57BLBile Acids and SaltsPrognosisUp-RegulationSkin NeoplasmsMetabolomicsGastrointestinal MicrobiomeImmunotherapy, AdoptiveTandem Mass SpectrometryMultiple MyelomaFatty AcidsSkin DiseasesLipaseAcyltransferases

Practice Location

4727 E CAMP LOWELL DR
TUCSON, AZ 85712-1256

Phone: (520) 290-4263

What does DAVID SIEGEL research?

David B. Siegel studies complex medical issues across several fields. He particularly focuses on multiple myeloma, a type of blood cancer, exploring new drug combinations and advanced therapies like CAR T-cell therapy to improve patient responses when previous treatments have failed. In addition, he investigates metabolic health, analyzing compounds and substances that affect metabolism, such as carnitines and specific gut microbial molecules, to develop better treatment strategies for patients with obesity and diabetes. His research also extends to orthopedic surgery, examining innovative surgical methods, like using custom implants in ankle replacements, to enhance recovery for patients with unsuccessful prior surgeries.

Key findings

  • In one study of multiple myeloma patients, 69.4% responded positively to CAR T-cell therapy, with effects lasting an average of 23.8 months.
  • After 36 months of using a custom fibula for total ankle replacement, patients experienced painless walking with no surgery site complications.
  • Researchers identified over 34,000 unique carnitine compounds, influencing better understanding of metabolic disorders and potential treatment pathways.

Frequently asked questions

Does Dr. Siegel study multiple myeloma?
Yes, Dr. Siegel researches new treatment methods for patients with multiple myeloma, including innovative drug combinations.
What kind of treatments has Dr. Siegel researched?
He has studied CAR T-cell therapy, drug combinations for cancer, and new surgical methods for ankle replacements.
Is Dr. Siegel's work relevant to patients with obesity?
Yes, his research into metabolites and specific compounds is focused on developing treatments for obesity and diabetes.
How does Dr. Siegel help with orthopedic issues?
He investigates innovative surgical techniques, such as using custom implants, to improve outcomes for patients with failed ankle surgeries.
What techniques does Dr. Siegel use in his research?
Dr. Siegel employs advanced analytical methods like mass spectrometry to study various substances related to health and disease.

Publications in plain English

Identification of menstrual blood markers by proteomic mass spectrometry.

2026

International journal of legal medicine

Yang H, Butler E, Monier S, Almubarak I, Siegel D

Plain English
This study looked at menstrual blood to find proteins that can help identify it, which is important for forensic cases like sexual assaults. Researchers used samples from 44 volunteers and found over 20 potential proteins that could confirm the presence of menstrual blood. This matters because having reliable markers can provide crucial evidence in legal situations. Who this helps: This helps forensic scientists and law enforcement officials in criminal investigations.

PubMed

Synthesis-driven reverse metabolomics reveals 3-hydroxy N-acyl amides as gut microbial molecules.

2026

bioRxiv : the preprint server for biology

Deleray V, Charron-Lamoureux V, Vittali K, Mannochio-Russo H, Wang CX +4 more

Plain English
This research focused on a group of molecules called 3-hydroxy-acyl amides, which have potential benefits for fighting obesity and regulating blood sugar but were hard to study because they aren’t commonly found in current research databases. The team created a new database with 436 different types of these molecules and discovered them in a wide variety of biological samples, including human saliva and stool. Notably, they found that levels of certain 3-hydroxy-acyl amides were different in people with diabetes, indicating their relevance to metabolic diseases. Who this helps: This research benefits patients, particularly those with obesity or diabetes, by identifying new targets for treatment and monitoring.

PubMed

Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.

2026

Cancer immunology research

Alsina M, Shah N, Jagannath S, Kaufman JL, Siegel D +16 more

Plain English
This study looked at a new treatment called bb21217, a type of CAR T-cell therapy designed for patients with multiple myeloma that has come back or did not respond to previous treatment. The researchers found that 69.4% of the 72 patients experienced a positive response, and those who responded saw benefits lasting an average of 23.8 months. The results show that this therapy is both safe and effective, especially when given early in the disease when the cancer burden is lower. Who this helps: This benefits patients with relapsed or refractory multiple myeloma.

PubMed

ATGL-catalyzed biosynthesis mediates the upregulation of fatty acid hydroxy fatty acids (FAHFA) levels in white adipose tissue with fasting.

2026

The Journal of biological chemistry

Santoro A, Chen Z, Nelson AT, Siegel D, Kahn BB

Plain English
This study looked at how fasting affects levels of certain beneficial fats called FAHFAs in fat tissue. Researchers found that when fasting occurs, a specific enzyme, ATGL, helps increase the production of these fats, particularly in belly fat, which suggests that fasting boosts the body’s ability to create these anti-inflammatory and anti-diabetic fats. For example, during fasting, there’s an increase in the synthesis of these fats without a corresponding increase in their breakdown, indicating that fasting encourages the body to make more of them. Who this helps: This research benefits patients looking to manage obesity and diabetes through dietary changes.

PubMed

MS/MS Mass Spectrometry Filtering Tree for Bile Acid Regio- and Stereoisomer Annotation.

2026

Analytical chemistry

Mohanty I, Xing S, Castillo V, Agongo J, Patan A +9 more

Plain English
This study focused on improving the identification of different types of bile acids, which play important roles in digestion and metabolism. Researchers developed a new method that helps differentiate similar bile acid isomers based on their chemical properties, finding that a previously unknown bile acid, called deoxycholyl--acetyl-putrescine, is more common in carnivorous animals. This is important because it can enhance our understanding of how diet affects biology across various species. Who this helps: This research benefits scientists studying metabolism and nutrition in different animals.

PubMed

A searchable metadata network graph for microbiome metabolomics.

2026

bioRxiv : the preprint server for biology

Charron-Lamoureux V, Xing S, Patan A, Walker C, Monter RA +62 more

Plain English
This study developed a tool called microbiomeMASST that organizes information about specific substances produced by microbes in a wide range of samples from humans, animals, and plants. By analyzing over 144,000 mass spectrometry files from 467 datasets, researchers found that the gut bacteria can change the active form of a heart medication, enalapril, making it ineffective. This work is important because it helps us understand how microbes influence drug effects in the body, which can lead to better treatments and medication guidelines. Who this helps: This benefits patients and doctors by improving medication effectiveness and understanding drug interactions in those taking antibiotics or with gut health issues.

PubMed

Molecular identification of Vel-negative blood donors in a population from southern Brazil.

2026

Vox sanguinis

Siegel D, Schörner EJ, Schörner MA, Grisard H, Barazzetti FH +2 more

Plain English
This study explored blood donations in southern Brazil to identify donors who are Vel-negative, a rare blood type that can cause complications during blood transfusions. Out of 17,472 blood samples tested, only 0.03% were found to be Vel-negative, and there was a 0.90% frequency of a specific genetic deletion linked to this blood type. Knowing who these Vel-negative donors are is important because it helps improve safety for patients requiring blood transfusions and supports better matching in rare donor registries. Who this helps: This benefits patients who need blood transfusions, especially those with rare blood types.

PubMed

Nested model comparisons between common factors and composites.

2026

Psychological methods

Siegel D, Savalei V, Rhemtulla M

Plain English
This study compares different ways to measure psychological traits using three models: a traditional model, a composite analysis model, and a pseudo-indicator model. The researchers found that these models can be analyzed together and are related, allowing for better comparisons through specific statistical tests. Understanding these models is important because it can improve how psychological data is interpreted and applied in research and practice. Who this helps: This helps psychologists and researchers in understanding and analyzing psychological measurements more effectively.

PubMed

Vestibular symptoms after talquetamab therapy in heavily pretreated multiple myeloma.

2026

Blood advances

Di Palma-Grisi J, Biran N, Phull P, Vesole D, Siegel D +1 more

PubMed

Navigating the conjugated metabolome.

2026

bioRxiv : the preprint server for biology

Xing S, Patan A, Agongo J, Gouda H, Charron-Lamoureux V +10 more

Plain English
This study explored a category of small molecules called conjugated metabolites, which are formed when different molecules bond together. By analyzing a massive database of chemical spectra, the researchers identified over 3.4 million potential conjugates and mapped their structures, revealing important links between diet, drugs, and the body’s metabolism. This research is significant because it creates a comprehensive reference for understanding these metabolites, which can influence health by acting as signals or regulators in the body. Who this helps: This benefits researchers and doctors looking to understand how various metabolites affect health and disease.

PubMed

Salvage Therapy in Multiple Myeloma With Prior T-Cell Engager Exposure: Talquetamab, Elranatamab or Teclistamab in Combination With Pomalidomide.

2026

European journal of haematology

Di Palma-Grisi J, Vesole D, Siegel D, Biran N, Phull P +1 more

Plain English
This study looked at the effectiveness of combining three drugs—talquetamab, elranatamab, or teclistamab—with another treatment called pomalidomide in 12 patients with multiple myeloma (MM) who had already tried several other therapies, including CAR-T therapy. Out of these patients, 11 showed a positive response to the treatment, with 6 achieving a significant improvement in their condition after about 10 months. These findings are important because they suggest a new viable treatment option for patients whose disease hasn't responded to prior therapies. Who this helps: This helps patients with multiple myeloma who haven't had success with other treatments.

PubMed

Social dimensions of Managed Aquifer Recharge: A scoping review.

2026

Journal of environmental management

Castro-Diaz L, du Bray MV, Beresford M, Jacob C, Jankovic-Rankovic J +6 more

Plain English
This study looked at how social factors impact Managed Aquifer Recharge (MAR), a method that helps manage water resources and combat climate change. Researchers reviewed 83 articles and found five key themes related to public acceptance, environmental benefits, health risks, policies, and community involvement. Understanding these social aspects is crucial for making MAR successful and equitable, especially as climate extremes increase. Who this helps: This benefits communities seeking sustainable water solutions and policymakers developing related strategies.

PubMed

Near-Infrared Vein Visualization for Point-Of-Care Diagnosis of Cutaneous Venous Malformations.

2026

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Buethe MG, Siegel D, Glick S, Shmuylovich L

PubMed

Pan-Metabolomics Repository Mapping of the Carnitine Landscape.

2026

bioRxiv : the preprint server for biology

Mannochio-Russo H, Ferreira PC, Kvitne KE, Patan A, Deleray V +14 more

Plain English
This study examined a group of substances called carnitines, which are important for various metabolic processes in the body. Researchers created a detailed library of over 34,000 unique carnitine compounds by analyzing data from multiple sources, which revealed more than 3.8 million instances of these compounds. This work is crucial because it enables better understanding and identification of carnitines, which can lead to new insights into health and disease related to metabolism. Who this helps: This benefits patients with metabolic disorders, doctors who treat them, and researchers studying metabolic health.

PubMed

Conversion of Failed Ankle Arthrodesis to Total Ankle Arthroplasty Using a Novel Custom Fibula in a Global Pes Cavus Deformity.

2026

Foot & ankle specialist

Schwab A, Siegel D, Glessner S, Derner R

Plain English
This study focused on a new method for patients who have previously had ankle surgery that didn’t work. Researchers used a custom-made fibula to help stabilize the ankle during a total ankle replacement, and after 36 months, patients were able to walk without pain, with no complications at the surgery site. This matters because it offers a new surgical option for people with failed ankle surgeries, improving their quality of life. Who this helps: This helps patients who have had unsuccessful ankle surgeries.

PubMed

Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Further structure-activity relationships.

2026

Bioorganic & medicinal chemistry

Dias TA, Siegel D, Ross D, Moody CJ

Plain English
This study focused on creating new compounds called indolequinones that can block a specific enzyme known as NQO2, which has implications in various diseases. The researchers improved the chemical process to produce these compounds more efficiently, reducing the amount of materials needed. Ultimately, they found several strong inhibitors that could help in targeting the NQO2 enzyme more effectively, which is important for developing new treatments. Who this helps: This benefits patients with diseases where NQO2 plays a role, such as certain cancers.

PubMed

The Evolving Role of Checkpoint Inhibitors in Multiple Myeloma.

2025

Clinical lymphoma, myeloma & leukemia

Chakrabarti R, Siegel D, Biran N

Plain English
This study looked at how checkpoint inhibitors (CKP-I) can be used to treat multiple myeloma, a type of cancer that affects plasma cells in the blood. Although checkpoint inhibitors have worked well for other cancers, they have shown limited success on their own for multiple myeloma. The researchers found that better understanding the immune system's role in this disease could lead to new ways to use checkpoint inhibitors effectively in the future. Who this helps: This research benefits patients with multiple myeloma by exploring potential new treatment options.

PubMed

Patient-derived glioblastoma organoids as real-time avatars for assessing responses to clinical CAR-T cell therapy.

2025

Cell stem cell

Logun M, Wang X, Sun Y, Bagley SJ, Li N +11 more

Plain English
This study looked at how well a new type of cancer treatment, called CAR-T cell therapy, works against glioblastoma, a hard-to-treat brain cancer. Researchers tested patient-derived tumor organoids (mini tumors grown from patients' cells) to see how they responded to the treatment. They found that the CAR-T cells successfully reduced tumor markers and killed cancer cells in these organoids, which matched what was seen in the patients' cerebrospinal fluid, making it a promising way to evaluate the treatment's effectiveness. Who this helps: This research benefits patients with glioblastoma and their doctors by providing better ways to personalize treatment approaches.

PubMed

Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma.

2025

Molecular and cellular biology

Oshikiri H, Taguchi K, Hirose W, Taniyama Y, Kamei T +5 more

Plain English
This study looked at a type of esophageal cancer that is tough to treat because it often resists chemotherapy due to a genetic change called NRF2 activation. Researchers created new versions of a drug called geldanamycin to target cancer cells while avoiding liver damage. They found that these new drugs were effective in attacking the cancer cells without harming the liver, suggesting a promising new treatment for patients with this specific type of cancer. Who this helps: This helps patients with NRF2-activated esophageal squamous cell carcinoma.

PubMed

Digital PCR Assay Utilizing In-Droplet Methylation-Sensitive Digestion for Estimation of Fetal cfDNA From Plasma.

2025

Prenatal diagnosis

Dannebaum R, Mikhaylichenko O, Siegel D, Li C, Hall E +13 more

Plain English
This study focused on a new method for measuring the amount of fetal DNA in the blood of pregnant women, which is important for accurate prenatal screenings. Researchers tested a technique called droplet digital PCR that uses a special enzyme to analyze DNA from 137 samples, finding it aligned well with existing advanced methods, particularly for both male and female pregnancies. The results were reliable, allowing for more affordable and fast testing, making prenatal screenings more effective. Who this helps: This benefits pregnant women and healthcare providers involved in prenatal care.

PubMed

Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data.

2025

British journal of haematology

Biran N, Dhakal B, Niesvizky R, Lentzsch S, Bhutani D +11 more

Plain English
This study looked at how a new gene test called SKY92 can help doctors better understand and treat multiple myeloma, a type of blood cancer. In a group of 251 newly diagnosed patients, SKY92 identified high-risk patients more accurately than traditional methods—only 28% of patients were deemed high-risk by SKY92 compared to 51% using standard assessments. After learning the SKY92 results, half of the doctors changed their treatment plans, and 40% felt more confident in their decisions. Who this helps: This benefits patients and doctors by providing more reliable risk assessments and treatment options.

PubMed

Specific FAHFAs predict worsening glucose tolerance in non-diabetic relatives of people with Type 2 diabetes.

2025

Journal of lipid research

Syed I, Sluis K, Aryal P, Solomon Z, Patel R +4 more

Plain English
This study looked at specific fatty acids in the blood called FAHFAs to see if they could help predict worsening glucose tolerance in people who have family members with Type 2 diabetes. Researchers found that low levels of a type of FAHFA called PAHSAs were linked to a higher chance of developing impaired glucose tolerance, while higher levels of another type called PAHOAs were associated with the same risk. Specifically, individuals who showed a decrease in PAHSAs or had higher levels of PAHOAs were more likely to experience glucose tolerance issues, regardless of their weight or body fat percentage. Who this helps: This information benefits patients who are at risk of developing Type 2 diabetes, especially those with a family history of the disease.

PubMed

The microbiome diversifies long- to short-chain fatty acid-derived N-acyl lipids.

2025

Cell

Mannochio-Russo H, Charron-Lamoureux V, van Faassen M, Lamichhane S, Gonçalves Nunes WD +43 more

Plain English
This study focused on a type of fat molecule called N-acyl lipids, which play a key role in immune function and stress responses. Researchers created a comprehensive database using information from over 2,700 studies, identifying 851 unique N-acyl lipids—many of which had not been recorded before. They discovered that the amounts of these lipids changed based on diet, the microbes in the gut, and conditions like diabetes, and they found links between certain lipids and health issues like HIV and cognitive impairment. Who this helps: This research benefits patients, especially those with diabetes or conditions affecting the immune system.

PubMed

Generation of human induced pluripotent stem cell lines from patients with PHACE syndrome.

2025

Stem cell research

Ramchandani R, Cheawsamoot C, Torres GA, Arthur Ataam J, Siegel D +1 more

Plain English
This study focused on patients with PHACE syndrome, a rare condition that includes various birth defects. Researchers took blood cells from three patients and created stem cell lines that behave like embryonic stem cells, which can develop into different types of cells. These stem cell lines are important for understanding PHACE syndrome better and testing new treatments. Who this helps: This helps researchers and doctors looking to improve care for patients with PHACE syndrome.

PubMed

Role of Serum Stability and Lipoprotein Interactions in Lipid Structure-Tumor Accumulation Relationship.

2025

ACS nano

Barnes A, Gaikwad HK, Siegel D, Angarita D, Nebbia M +9 more

Plain English
Researchers studied how different types of lipid (fat) structures impact their ability to reach and accumulate in tumors. They found that certain lipids with stable linkers and longer tail chains accumulated more effectively in tumors, while those with unstable connections cleared quickly from the body. Specifically, two lipids, DiI-C18 and DiI-C22, showed the best results in breast cancer and glioma models, hinting that stability and lipid design are key for effective drug delivery. Who this helps: This helps patients undergoing cancer treatment by improving how medications are delivered to tumors.

PubMed

Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting.

2025

Journal of drugs in dermatology : JDD

Romanelli S, Ball GD, Zhang AJ, Asare C, Hao A +22 more

Plain English
The 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting focused on improving how dermatological diseases are researched and treated. Various groups discussed progress in areas such as psoriasis, acne, and skin cancer, with each presenting important findings relevant to patient care. This effort is crucial because it ensures that treatments are effective and based on solid research. Who this helps: This helps patients with skin conditions by improving their treatment options.

PubMed

Charting the Undiscovered Metabolome with Synthetic Multiplexing.

2025

bioRxiv : the preprint server for biology

Patan A, Xing S, Charron-Lamoureux V, Hu Z, Deleray V +27 more

Plain English
Researchers studied a vast collection of chemical patterns in biological samples to better understand substances in living organisms, revealing that only a tiny fraction of these patterns are currently identified. They synthesized over 100,000 new chemical compounds, 91% of which were not in existing databases. This work improved identification rates for chemical structures by 17.4%, increasing the total identification rate from 6.9% to 8.1% and uncovering new substances that can arise from interactions between drugs and the body, such as ibuprofen derivatives. Who this helps: This benefits researchers and healthcare professionals looking to understand how different substances affect health and disease.

PubMed

Human stem cell models for group 3 medulloblastoma uncover JARID1B as a regulator of the chromatin landscape.

2025

bioRxiv : the preprint server for biology

Qadeer ZA, Hou E, Siegel D, Westelman S, Gudenas B +13 more

Plain English
This study focused on group 3 medulloblastoma (G3MB), a dangerous type of brain tumor in children that has low survival rates and no effective targeted treatments. Researchers created human stem cell models to explore the underlying mechanisms of G3MB and discovered that the proteins MYC and TGFβR1 work together to drive tumor growth and make it resistant to treatments. They found that a protein called JARID1B, which is linked to MYC, plays a key role in this process; reducing JARID1B levels in cancer cells slowed their growth, suggesting it could be a new treatment target. Who this helps: This benefits children with group 3 medulloblastoma and their doctors by providing potential new targets for therapy.

PubMed

Susceptibility of Glucose Regulation to Social Isolation.

2025

bioRxiv : the preprint server for biology

Lamont HH, Oyama R, Munoz PD, Siegel D, Baringanire P +4 more

Plain English
This study examined how social isolation affects blood sugar regulation in young male mice. Researchers found that when these mice were kept alone for at least three weeks, their blood sugar levels became significantly elevated, but this issue was reversed when they were placed back with other mice. Importantly, this effect did not occur in females, indicating that male hormones play a role in how social isolation impacts glucose control. Who this helps: This helps researchers and clinicians understand how social interactions influence metabolic health, particularly in men.

PubMed

MS/MS Mass Spectrometry Filtering Tree for Bile Acid Isomer Annotation.

2025

bioRxiv : the preprint server for biology

Mohanty I, Xing S, Castillo V, Agongo J, Patan A +21 more

Plain English
This study focused on developing a new method to identify different types of bile acids, which play important roles in our body, using mass spectrometry—a technique for analyzing substances. The researchers found a specific bile acid linked to eating whole grains. This is important because it provides insight into how our diet can affect our health by influencing bile acid composition. Who this helps: Patients and nutritionists looking to understand the health benefits of whole grains.

PubMed

Evidence-based consensus on the clinical application of photobiomodulation.

2025

Journal of the American Academy of Dermatology

Maghfour J, Mineroff J, Ozog DM, Jagdeo J, Lim HW +18 more

Plain English
Researchers aimed to create clear guidelines for using photobiomodulation (PBM), a light-based therapy, after finding a lack of consensus among clinicians. They reviewed studies and gathered a panel of 21 experts who agreed that PBM is safe for adults and effective for conditions like neuropathy, hair loss, and various types of wounds, with no DNA damage caused by red light PBM. This is important because it provides healthcare providers with reliable information to use PBM safely and effectively in treating patients. Who this helps: This benefits patients suffering from nerve pain, hair loss, and chronic wounds.

PubMed

Reducing Cancer Risk Through Primary Prevention Activities Among Children: A Demonstration Project.

2024

Journal of public health management and practice : JPHMP

Tai E, Chovnick G, Momin B, Townsend JS, Holman DM +2 more

Plain English
This study looked at ways to lower the risk of certain cancers in children, specifically cervical, liver, and skin cancer. In Iowa, health care providers reported better awareness and attitudes about the HPV vaccine after an educational program, while Pennsylvania launched programs in state parks to teach kids about sun safety and provide access to sunscreen. The findings point out that early education and health policies can effectively protect children from cancer later in life. Who this helps: This benefits children, parents, and health care providers.

PubMed

Reverse metabolomics for the discovery of chemical structures from humans.

2024

Nature

Gentry EC, Collins SL, Panitchpakdi M, Belda-Ferre P, Stewart AK +25 more

Plain English
This study looked at how to identify and understand molecules in the human body using a method called reverse metabolomics. Researchers discovered that certain bile acids are linked to inflammatory bowel disease (IBD), finding that people with Crohn's disease had higher levels of specific compounds, like cholic acids linked to amino acids, in their systems. This is important because understanding these relationships can help in diagnosing and treating IBD more effectively. Who this helps: Patients with inflammatory bowel disease.

PubMed

Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.

2024

Journal of drugs in dermatology : JDD

Zakria D, Brownstone N, Berman B, Ceilley R, Cronin TA +4 more

Plain English
This study looked at how a specific test, called the 40-gene expression profile (40-GEP), can help doctors better predict the risk of spread (metastasis) in patients with cutaneous squamous cell carcinoma (cSCC), a common skin cancer. The expert panel reviewed 21 relevant studies and agreed on 7 key recommendations about using this test, noting that it gives valuable information that standard methods do not provide. Incorporating the 40-GEP test into clinical practice could help identify higher-risk patients sooner, potentially improving patient outcomes. Who this helps: This helps patients with cutaneous squamous cell carcinoma and their doctors.

PubMed

Media Forensic Considerations of the Usage of Artificial Intelligence Using the Example of DeepFake Detection.

2024

Journal of imaging

Siegel D, Kraetzer C, Seidlitz S, Dittmann J

Plain English
This study looked at how upcoming European regulations will affect the use of high-risk artificial intelligence systems, particularly in detecting DeepFakes. Researchers found that while involving humans in AI decisions can help prevent mistakes, it can also introduce new errors. This matters because it aims to ensure that AI systems are reliable and transparent, which is crucial as they become more integrated into important decisions. Who this helps: This helps lawmakers and AI developers.

PubMed

The underappreciated diversity of bile acid modifications.

2024

Cell

Mohanty I, Mannochio-Russo H, Schweer JV, El Abiead Y, Bittremieux W +23 more

Plain English
This study looked at the different changes that bile acids and related substances undergo in the body, revealing a wealth of modifications that scientists hadn't fully explored before. By analyzing a massive database of mass spectrometry data, researchers discovered that a specific type of bile acid modification is common in meat-eating animals and is also found in humans, with levels changing when people switch from a Mediterranean diet to a typical American diet. These findings are important because they open up new avenues for understanding how bile acids affect health and disease. Who this helps: This helps researchers and healthcare providers by providing new insights into dietary impacts on bile acid metabolism.

PubMed

Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cells.

2024

BMC biology

Panina SB, Schweer JV, Zhang Q, Raina G, Hardtke HA +4 more

Plain English
This study focused on glioblastoma, a very aggressive type of brain cancer, and explored how targeting a protein called REST could help treat it. Researchers found that some glioblastoma cells rely on REST to grow, and by using specially designed small molecules to inhibit REST, they could significantly reduce its levels and the growth of these cancer cells. Specifically, one of these compounds, named GR-28, was particularly effective; it worked well alongside another treatment, Triacsin C, allowing for better control of tumor growth without damaging the liver. Who this helps: This benefits patients with glioblastoma, particularly those with high levels of REST.

PubMed

Tracking Inhibition of Human Small C-Terminal Domain Phosphatase 1 Using 193 nm Ultraviolet Photodissociation Mass Spectrometry.

2024

Journal of the American Society for Mass Spectrometry

Escobar EE, Yang W, Lanzillotti MB, Juetten KJ, Shields S +3 more

Plain English
This study examined how two drugs, T65 and rabeprazole, bind to a protein called human small C-terminal domain phosphatase 1 (SCP1) and a mutant version of it. Researchers found that both drugs interact differently with the normal and mutated proteins, which helps us understand how effective these drugs might be at targeting this phosphatase. This understanding is important because it can lead to better treatments for diseases where these proteins play a role. Who this helps: This helps researchers and doctors looking to improve therapies for various diseases.

PubMed

Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradation.

2024

Biomarker research

Orlikova-Boyer B, Lorant A, Gajulapalli SR, Cerella C, Schnekenburger M +11 more

Plain English
This study looked at how a drug called MAC681 affects chronic myeloid leukemia (CML) cells, especially those resistant to standard treatments. The researchers found that MAC681 caused significant cell damage and death in both sensitive and resistant CML cells by disrupting their energy production and degrading a protein called PARP1, which is more active in CML cells than in healthy cells. This is important because it suggests that MAC681 could enhance existing therapies and strengthen immune responses against leukemia, potentially leading to better outcomes for patients. Who this helps: This helps patients with chronic myeloid leukemia, particularly those who have become resistant to current treatments.

PubMed

Beneficial metabolic effects of PAHSAs depend on the gut microbiota in diet-induced obese mice but not in chow-fed mice.

2024

Proceedings of the National Academy of Sciences of the United States of America

Lee J, Wellenstein K, Rahnavard A, Nelson AT, Holter MM +7 more

Plain English
This study looked at how a type of dietary fat, called PAHSAs, affects metabolism in mice that are obese due to a high-fat diet compared to those on a regular diet. The researchers found that while PAHSAs improved insulin sensitivity in mice on a standard diet, these benefits were lost when the mice switched to a high-fat diet. Additionally, when feces from mice treated with PAHSAs were transferred to high-fat diet mice, it helped improve their insulin sensitivity, showing that gut bacteria played a key role in these effects. Who this helps: This research benefits patients with obesity and diabetes by highlighting potential dietary strategies to improve insulin sensitivity through gut health.

PubMed

Development of a Prepharmacy Underrepresented Mentorship Program for Undergraduate Students.

2024

American journal of pharmaceutical education

Mnatzaganian CL, Fricovsky E, Cartlidge C, Siqueira-Neto J, Siegel D +3 more

Plain English
Researchers created a mentorship program called PUMP to support prepharmacy students interested in helping underrepresented communities facing health challenges. Over three admissions cycles, 189 students attended workshops, and 34% more of those who participated ended up enrolling in pharmacy school compared to previous years. Most attendees reported that the program improved their view of the school, making it a valuable resource for those dedicated to making a difference in diverse communities. Who this helps: This benefits prepharmacy students and the communities they aim to serve.

PubMed

Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014.

2024

Clinical lymphoma, myeloma & leukemia

Bahlis NJ, Samaras C, Reece D, Sebag M, Matous J +14 more

Plain English
This study looked at a combination treatment of pomalidomide, daratumumab, and dexamethasone for patients with relapsed or refractory multiple myeloma who had already tried lenalidomide. After about 42 months of follow-up, the median overall survival for the patients was 56.7 months, showing that this treatment can help extend life. The side effects were manageable, and no new safety issues were found. Who this helps: This benefits patients with multiple myeloma who have run out of options after lenalidomide treatment.

PubMed

Geldanamycin, a Naturally Occurring Inhibitor of Hsp90 and a Lead Compound for Medicinal Chemistry.

2024

Journal of medicinal chemistry

Kitson RRA, Kitsonová D, Siegel D, Ross D, Moody CJ

Plain English
This paper studies geldanamycin, a natural compound that inhibits a protein called Hsp90, focusing on how its chemical structure can be modified to create new drugs. Researchers found that altering specific parts of geldanamycin can lead to compounds that are less toxic and still effective in targeting cancer cells, with some of these new versions already tested in clinical trials. This research is important because it could lead to safer cancer treatments while maintaining effectiveness. Who this helps: This helps patients with cancer.

PubMed

Impact of Allogeneic Stem Cell Transplant on Safety and Outcomes of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Patients with Multiple Myeloma (MM).

2024

Journal of clinical medicine

Bangolo A, Amoozgar B, Zhang L, Nagesh VK, Sekhon I +7 more

Plain English
This study looked at how well CAR-T therapy works and how safe it is for patients with multiple myeloma (MM) who have previously received an allogeneic stem cell transplant. Among 56 patients treated, those with a prior transplant showed an overall response rate of 87.5%, compared to 75% for those without prior transplants, and no treatment-related deaths were reported. These findings matter because they suggest that CAR-T therapy can be safe and effective for a group of patients who have historically been excluded from this treatment option. Who this helps: This benefits patients with relapsed or refractory multiple myeloma who have undergone stem cell transplants.

PubMed

Acute inflammation upregulates FAHFAs in adipose tissue and in differentiated adipocytes.

2024

The Journal of biological chemistry

Ertunc ME, Konduri S, Ma Z, Pinto AFM, Donaldson CJ +3 more

Plain English
This study looked at how inflammation affects certain fatty acids in fat tissue, specifically two types known as FAHFAs, which are produced during the inflammatory response. The researchers found that inflammation boosts the production of these fatty acids, and while the naturally occurring levels might not reduce inflammation, there is potential for converting harmful fatty acids into FAHFAs that could lessen inflammation. This is important because it suggests that enhancing FAHFA production might offer a new way to manage inflammation-related conditions. Who this helps: This helps patients dealing with inflammation-related health issues.

PubMed

The microbiome diversifies-acyl lipid pools - including short-chain fatty acid-derived compounds.

2024

bioRxiv : the preprint server for biology

Mannochio-Russo H, Charron-Lamoureux V, van Faassen M, Lamichhane S, Nunes WDG +40 more

Plain English
This study focused on a group of compounds called acyl lipids, which are involved in important functions like supporting the immune system and responding to stress. The researchers built a comprehensive library based on data from 2,700 studies, identifying a total of 851 unique acyl lipids, many of which hadn't been recorded before. They found that these compounds can change depending on a person's diet and health conditions, particularly in those with diabetes, and some are associated with HIV and cognitive issues. Who this helps: This research benefits patients, especially those with diabetes, HIV, or cognitive impairments, by improving our understanding of how diet and gut bacteria influence health.

PubMed

Creating an Empirical Dermatology Dataset Through Crowdsourcing With Web Search Advertisements.

2024

JAMA network open

Ward A, Li J, Wang J, Lakshminarasimhan S, Carrick A +16 more

Plain English
This study looked at whether online ads could gather a diverse range of images of skin conditions for a new dermatology dataset. Researchers collected 5,749 submissions, with 97.9% being valid images. They found that women and younger people were overrepresented compared to the general U.S. population, and the dataset is particularly useful in identifying common skin issues over short timeframes. Who this helps: This benefits researchers, doctors, and patients by providing better resources for diagnosing and studying skin conditions.

PubMed

Examining the Occurrence and Clinical Impact of Difficult Experiences that Emerge during a Mindfulness-Based Intervention among Individuals at High-Risk of Suicide.

2024

Mindfulness

Interian A, Miller R, Dave C, Latorre M, St Hill L +6 more

Plain English
This study looked at how often people at high risk of suicide experienced difficulties, like anxiety or hallucinations, during mindfulness practices. Out of 50 participants, 18% reported having these difficulties. However, these experiences did not lead to a higher risk of serious outcomes like suicide events or hospitalizations over the next year. Who this helps: This research helps patients and mental health professionals understand the impact of mindfulness practices for those at high risk of suicide.

PubMed

Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report.

2023

Journal of drugs in dermatology : JDD

Zakria D, Brownstone N, Berman B, Ceilley R, Cronin TA +4 more

Plain English
This study focused on a test called the 40-gene expression profile (40-GEP) that helps predict the risk of cutaneous squamous cell carcinoma (cSCC) spreading, which is a type of skin cancer. The research confirmed that this test offers valuable information that goes beyond traditional staging methods, with 6 out of 7 consensus recommendations rated as very strong. Including the 40-GEP test in treatment guidelines can help doctors better identify patients at higher risk of the cancer spreading, potentially improving patient outcomes. Who this helps: This helps patients with cutaneous squamous cell carcinoma by providing more accurate risk assessments.

PubMed

Beneficial metabolic effects of PAHSAs depend on the gut microbiota in diet-induced obese mice.

2023

bioRxiv : the preprint server for biology

Lee J, Wellenstein K, Rahnavard A, Nelson AT, Holter MM +7 more

Plain English
This study looked at how a type of dietary fat called PAHSAs affects metabolism and insulin sensitivity in mice that are obese due to a high-fat diet. Researchers found that PAHSAs helped female mice improve their insulin sensitivity and gain less weight, but only when their gut bacteria were present; germ-free mice didn't benefit from PAHSAs alone. This matters because it shows that the gut microbiota plays a crucial role in how these dietary fats can improve metabolic health, particularly in females, which could lead to better treatments for obesity-related issues. Who this helps: Patients struggling with obesity and metabolic disorders, particularly women.

PubMed

Frequent Co-Authors

Pieter C Dorrestein Mingxun Wang Jasmine Zemlin Helena Mannochio-Russo Abubaker Patan Yasin El Abiead Ipsita Mohanty Shipei Xing Victoria Deleray Julius Agongo

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.